Newsletter | April 15, 2026

04.15.26 -- Beyond Capacity: Fill/Finish Capabilities That Matter

 

 

As fill/finish becomes a critical inflection point for injectable programs, success hinges on identifying partners with the right aseptic capabilities, formats, and executional experience at the moment it matters most. That’s why the Outsourced Pharma Capacity Update has evolved into the Outsourced Pharma Capabilities Update (OPCU) — a series designed to go beyond capacity and highlight the real differentiators: the technologies, experience, and specialized capabilities CDMOs bring to your programs.

 

Across these sessions, you’ll get a clear view into the most critical stages of development — and how the right partners can help reduce cycle times, strengthen quality, and de-risk scale-up for small molecule assets.

 

Tune in each month to our expanded PARTNER WEEK, organized by capability area, which makes it easier than ever to pinpoint the right CDMO strengths — exactly when you need them.

 

Recent Sessions Available On-Demand        
Large Molecule – 3/10/2026, AM Session      
Fill / Finish – 3/10/2026, PM Session

 

Upcoming OPCU Topics & Times

Small Molecule Drug Product | 4/21/2026, AM Session        
Fill/Finish | 4/22/2026, PM Session   

 

Access more on-demand OPCU recordings and upcoming sessions here.

FILL/FINISH

Argonaut

Aseptic, isolator‑based fill‑finish spans multiple formats and batch sizes, supported by onsite analytics that cut hand‑offs and streamline testing. Learn how this setup boosts efficiency.

Request Information

Argonaut Manufacturing Services

Novartis

Integrated fill‑finish capabilities across sterile formats improve efficiency, ensure consistency, and support planning for scale‑up and long‑term commercialization.

Request Information

Novartis Contract Manufacturing

medac CDMO

A purpose‑built sterile manufacturing model enables reliable scale‑up, operational agility, and resilient global supply for complex injectables, supported by strong infrastructure and process design.

Request Information

medac CDMO

Jubilant HollisterStier

Reliable sterile manufacturing requires tailored support and consistent execution. Collaboration and strong quality systems help teams advance complex injectable products with confidence.

Request Information

Jubilant HollisterStier

ROIS

End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.

Request Information

ROIS